Rechallenge, reassess, escalate. On paper.
A working reference for clinicians who see the same patients we do — the ones who've tried and stopped statins, who need a written path forward, and whose insurers want documentation before approving anything else.
Protocol library
Six referenced frameworks covering intolerance, cirrhosis, FH, Lp(a), triglycerides, and LDL goals.
PA scaffolds
Templates for PCSK9 inhibitors and bempedoic acid, structured around prior statin exposure and intolerance documentation.
Rechallenge tables
Once-weekly to daily titration, with CK triggers and step-back rules.
LDL target reference
Prevention, secondary prevention, FH, and severe primary hypercholesterolemia thresholds.
Protocols, in one place.
Supervised Rosuvastatin Rechallenge
Statin intolerance with elevated cholesterol
Lipid Therapy in Decompensated Cirrhosis
Statin use with decompensated liver cirrhosis
Familial Hypercholesterolemia (FH)
Suspected or confirmed FH with aggressive LDL targets
Hypertriglyceridemia
Mild to marked triglyceride elevation
LDL Cholesterol Goals — Extended Reference
Prevention framework and target thresholds
Isolated Elevated Lp(a)
Genetically driven cardiovascular risk enhancer
Reviewing physicians and clinical partners.
Clinicians who have executed a written CSPN Working Group Agreement with My Heart Spark, PC access their workspace at no charge. If that's you, use your issued CSPN Working Group code at checkout — or skip payment entirely from your Working Group dashboard. CME funds may also cover eligible workspace access.